A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of entospletinib in combination with intensive induction and consolidation chemotherapy in adults with newly diagnosed nucleophosmin 1-mutated acute myeloid leukemia Meeting Abstract
| Authors: | Byrd, J. C.; Cortes, J. E.; Minden, M. D.; Oellerich, T.; Stein, E. M.; Elder, J.; Kumar, P.; Bray, G.; DiMartino, J.; Stock, W. |
| Abstract Title: | A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of entospletinib in combination with intensive induction and consolidation chemotherapy in adults with newly diagnosed nucleophosmin 1-mutated acute myeloid leukemia |
| Meeting Title: | 63nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736398805014 |
| DOI: | 10.1182/blood-2021-145773 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1282 -- Hybrid meeting, also took place online -- Source: Wos |
